Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome
Status:
Completed
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
In this study, we aim to determine whether combined tolterodine and CPAP therapy is a more
effective treatment for patients with OSAS than CPAP treatment only.